,subjSummary,subj,rel,obj,objSummary,ref
0,SSRIs,Selective serotonin reuptake inhibitors (SSRIs),first-line treatment,Major Depressive Disorder during the acute phase,MDD acute phase,"pharmacotherapy, especially selective serotonin reuptake inhibitors antidepressant, remain the most frequent option for treating depression during the acute phase"
1,ECT,Electroconvulsive therapy (ECT),Highly effective,somatic therapy for depression in some specific situation,Depression specific situations,electroconvulsive therapy be the most effective somatic therapy for depression in some specific situation
2,MDD treatment,Treatment during the acute phase of a major depressive episode,Goal,help the patient reach a remission state and eventually return to their baseline level of functioning,Remission and returning to baseline,treatment during the acute phase of a major depressive episode aim to help the patient reach a remission state and eventually return to their baseline level of function
3,Depression,Depression,Associated with,high rate of suicidal behavior and mortality,suicidal behavior and mortality,depression be also associate with high rate of suicidal behavior and mortality
4,MAOIs,Monoamine oxidase inhibitors (MAOIs),Less commonly used,over time due to numerous side effects,Numerous side effects,"due to their irreversible inhibition of monoamine oxidase, moais have numerous side effects"
5,MAOIs,Monoamine oxidase inhibitors (MAOIs),Specific efficacy in treating,depression with atypical features,Atypical depression,maois have demonstrate specific efficacy in treating depression with atypical features
6,MAOIs,Monoamine oxidase inhibitors (MAOIs),second-line treatment,patients who have not responded to several other pharmacotherapies,Non-responders to other therapies,they be now almost exclusively prescribed for patients who have not responded to several other pharmacotherapies
0,MAOIs,Monoamine Oxidase Inhibitors (MAOIs),Definition,"the first class of antidepressants, defined by their mechanism of irreversible inhibition of the enzyme monoamine oxidase",Antidepressant class,iproniazid be the first drug define as an antidepressant; it be later classify as a monoamine oxidase inhibitor (maoi)
1,MAOIs,Monoamine Oxidase Inhibitors (MAOIs),Side effects,hepatotoxicity and hypertensive crisis that can lead to lethal intracranial hemorrhage,Adverse reactions,"due to their irreversible inhibition of monoamine oxidase, moais have numerous side effect, such as hepatotoxicity and hypertensive crisis, that can lead to lethal intracranial hemorrhage."
2,MAOIs,Monoamine Oxidase Inhibitors (MAOIs),Less commonly used,due to their complex side effects and dietary restrictions,Usage decline,"consequently, maois have become less commonly use over time"
3,MAOIs,Monoamine Oxidase Inhibitors (MAOIs),Specific efficacy in treating,depression with atypical features,Atypical depression,"maois have demonstrate specific efficacy in treat depression with atypical feature, such as reactive mood, reverse neuro-vegetative symptom, and sensitivity to rejection"
4,SSRIs,Selective Serotonin Reuptake Inhibitors (SSRIs),first-line treatment,for patients with major depression,Major depression,most guideline currently recommend ssris as the first-line treatment for patient with major depression
5,SSRIs,Selective Serotonin Reuptake Inhibitors (SSRIs),Side effects,"sexual and digestive (nausea and loss of appetite), as well as irritability, anxiety, insomnia, and headache",Adverse reactions,"they have elicit different tolerance rate and side effect- mostly sexual and digestive (nausea and loss of appetite), as well as irritability, anxiety, insomnia, and headache"
6,Ketamine,Ketamine,Side effects,"dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms",Adverse reactions,"common adverse effect of ketamine include dizziness, neurotoxicity, cognitive dysfunction, blur vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptom"
7,Ketamine,Ketamine,Treats,resistant unipolar and possibly bipolar depression and acute suicidal ideation,Depression & ideation,"in intravenous sub-anesthetic dose, ketamine have very quick effect on resistant unipolar (and, possibly, bipolar) depression and acute suicidal ideation"
8,Ketamine,Ketamine,Highly effective,for treatment-resistant depression,Treatment-resistant depression,"in intravenous sub-anesthetic dose, ketamine have very quick effect on resistant unipolar (and, possibly, bipolar) depression and acute suicidal ideation"
0,SSRIs,Selective serotonin reuptake inhibitors (SSRIs),first-line treatment,major depression,Major Depression,most guideline currently recommend ssris as the first-line treatment for patient with major depression.
1,MAOIs,Monoamine oxidase inhibitors (MAOIs),specific efficacy in treating,depression with atypical features,Atypical Depression,maois have demonstrate specific efficacy in treat depression with atypical feature.
2,MAOIs,Monoamine oxidase inhibitors (MAOIs),less commonly used,over time due to side effects,Over Time,"due to their irreversible inhibition of monoamine oxidase, moais have numerous side effects."
3,TCAs,Tricyclic antidepressants (TCAs),more effective,than SSRIs in treating hospitalized patients with severe major depressive disorder,Hospitalized Patients,some tcas can be more effective than ssris when use to treat hospitalized patient.
4,Bupropion,Bupropion,side effects,more likely than some SSRIs to lead to minimal weight gain or even weight loss,Weight Change,"bupropion have a well tolerability profile, with minimal weight gain (or even lead to weight loss)."
5,Ketamine,Ketamine,treats,treatment-resistant depression,Treatment-Resistant Depression,"intravenous sub-anesthetic dose, ketamine have very quick effect on resistant unipolar (and, possibly, bipolar) depression."
6,Esketamine,Esketamine (S-ketamine),approved for,treatment-resistant depression by the FDA,FDA Approval,it be approve by the united state food and drug administration in march 2019 for treatment-resistant depression.
7,Ketamine,Ketamine,side effects,"neurotoxicity, cognitive dysfunction, and potential for drug abuse",Side Effects,"common adverse effect of ketamine include dizziness, neurotoxicity, cognitive dysfunction."
8,CBT,Cognitive-behavioral therapy (CBT),widely used,for treating major depressive disorder,MDD Treatment,cbt be one of the most well-document and validate psychotherapeutic method available.
0,SSRIs,Selective Serotonin Reuptake Inhibitors (SSRIs),first-line treatment,major depression,Major Depression,most guidelines currently recommend SSRIs as the first-line treatment for patients with major depression
1,CBT,Cognitive Behavioral Therapy (CBT),first-line treatment,mild to moderate major depressive disorder,Mild to Moderate MDD,"CBT is considered the initial treatment method for mild to moderate MDD, based on significant clinical evidence"
2,IPT,Interpersonal Therapy (IPT),first-line treatment,mild to moderate major depressive episode in adults,Mild to Moderate MDD in Adults,"IPT, like CBT, is a first-line treatment for mild to moderate major depressive episode in adults"
3,Exercise,Physical Exercise,recommended,adjunct to other anti-depressive treatment,Adjunct Treatment,exercise is considered an adjunct to other anti-depressive treatment
4,MAOIs,Monoamine Oxidase Inhibitors (MAOIs),less commonly used,due to their irreversible inhibition of monoamine oxidase and numerous side effects,Due to Side Effects,"due to their irreversible inhibition of monoamine oxidase, MAOIs have numerous side effects that can lead to lethal intracranial hemorrhage, making them less commonly used over time"
5,Bupropion,Bupropion,side effects,"minimal weight gain or even weight loss, more likely to improve symptoms of fatigue and sleepiness than some SSRIs",Weight and Fatigue,bupropion is more likely than some SSRIs to lead to minimal weight gain or even weight loss and is more likely to improve symptoms of fatigue and sleepiness
6,Ketamine,Ketamine,associated with,"short antidepressant effect, possible neurotoxicity, and drug dependence",Side Effects,ketamine has a short antidepressant effect and is associated with possible neurotoxicity and drug dependence
7,Esketamine,Esketamine,approved for,treatment-resistant depression,Treatment-Resistant Depression,Esketamine was approved by the United States Food and Drug Administration in March 2019 for treatment-resistant depression
8,Therapeutic Monitoring,Therapeutic Monitoring of Ketamine Treatment,lacks guidelines,for depression,Depression,the current lack of guidelines about the therapeutic monitoring of ketamine treatment for depression further complicates the expanded use of this treatment
9,CBASP,Cognitive Behavioral Analysis System of Psychotherapy (CBASP),recommended for,chronic depression,Chronic Depression,"CBASP is recommended for treating chronic depression, utilizing specific approaches suited to each patient's preference"
0,SSRIs,Selective Serotonin Reuptake Inhibitors (SSRIs),first-line treatment,Major Depression,Major Depression,most guideline currently recommend SSRIs as the first-line treatment for patient with major depression.
1,ECT,Electroconvulsive therapy (ECT),Highly effective,All Depression,All Depression,"ECT be arguably the most effective treatment modality in psychiatry, and its superiority over pharmacotherapy for major unipolar depression be widely support."
2,MAOIs,Monoamine Oxidase Inhibitors (MAOIs),Less commonly used,Major Depression,Major Depression,MAOIs have become less commonly used over time due to their side effects.
3,Bupropion,Bupropion,Side effects,Minimal weight gain or even weight loss,Weight Change,"bupropion have a well tolerability profile than SSRIs, with minimal weight gain (or even lead to weight loss)."
4,Ketamine,Ketamine,Treats,Treatment-resistant Major Depression,Treatment-resistant Depression,"ketamine have very quick effect on resistant unipolar (and, possibly, bipolar) depression and acute suicidal ideation"
5,Psychotherapy,Psychotherapy,Treats,Mild to moderate Major Depression,Mild to moderate Depression,depression-focus psychotherapy be typically consider the initial treatment method for mild to moderate MDD.
6,CBT,Cognitive-Behavioral Therapy (CBT),first-line treatment,Major Depression,Major Depression,CBT be on of the most well-document and validate psychotherapeutic method available.
7,Exercise,Physical exercise,Associated with,Improvement in quality of life for depression patients,Quality of Life Improvement,exercise also promote improvement in one’s quality of life in general.
8,rTMS,Repetitive Transcranial Magnetic Stimulation (rTMS),More effective,Depression with mild side effects,Mild Side Effects,"treatment combine rtms and antidepressant be significantly more effective than placebo condition, with mild side effect and good acceptability."
9,Vortioxetine,Vortioxetine,Benefits,Depression-related cognitive impairment,Cognitive Impairment,"vortioxetine, have particular benefit in depression-relate cognitive impairment."
10,MBCT,Mindfulness-Based Cognitive Therapy (MBCT),Benefits,High risk of depressive relapse,Preventing Relapse,study have show that eight week of MBCT treatment during remission reduce relapse.
0,SSRIs,Selective Serotonin Reuptake Inhibitors (SSRIs),first-line treatment,major depression,major depression,most guideline currently recommend SSRIs as the first-line treatment for patients with major depression
1,MAOIs,Monoamine Oxidase Inhibitors (MAOIs),less commonly used,"due to irreversible inhibition of monoamine oxidase, numerous side effects such as hepatotoxicity and hypertensive crisis",side effects,"due to their irreversible inhibition of monoamine oxidase, MAOIs have numerous side effects, such as hepatotoxicity and hypertensive crisis, that can lead to lethal intracranial hemorrhage"
2,TCAs,Tricyclic Antidepressants (TCAs),Comparable to,SSRIs and MAOIs in treating major depression,other antidepressants,"TCAs, such as amitriptyline, nortriptyline, protriptyline, imipramine, desipramine, doxepin, and trimipramine are about as effective as other classes of antidepressants - including SSRIs, SNRIs, and MAOIs - in treating major depression"
3,ECT,Electroconvulsive Therapy (ECT),most effective,somatic therapy for resistant forms of depression in specific situations,resistant depression,Electroconvulsive therapy is the most effective somatic therapy for depression in some specific situations
4,Physical exercise,Physical exercise,associated with,improvements in quality of life and adjunct to other antidepressant treatment for depression,improvements in quality of life,"exercise also promotes improvement in one's quality of life in general. However, exercise is considered an adjunct to other anti-depressive treatment"
5,Ketamine,Ketamine,highly effective,in intravenous sub-anesthetic dose for resistant unipolar and possibly bipolar depression and acute suicidal ideation,resistant depression and suicidal ideation,"In intravenous sub-anesthetic dose, ketamine have very quick effect on resistant unipolar (and possibly, bipolar) depression and acute suicidal ideation"
6,CBT,Cognitive-Behavioral Therapy (CBT),first-line treatment,mild to moderate major depressive disorder,mild to moderate MDD,CBT is considered one of the most well-documented and validated psychotherapeutic methods available and is recommended as a first-line treatment for mild to moderate major depressive disorder
7,IPT,Interpersonal Therapy (IPT),first-line treatment,mild to moderate major depressive episodes in adults,mild to moderate major depressive episodes,"IPT, like CBT, is a first-line treatment for mild to moderate major depressive episodes in adults and is also a well-established intervention for adolescents with depression"
0,SSRIs,Selective Serotonin Reuptake Inhibitors (SSRIs),first-line treatment,Major Depression,Major Depression,most guideline currently recommend SSRIs as the first-line treatment for patients with major depression.
1,Physical activity,Regular physical activity,Associated with,alleviation of depressive symptoms and prevention of relapse,symptom relief,most guidelines for treating depression recommend that depressed patients perform regular physical activity to alleviate symptoms and prevent relapse.
2,ECT,Electroconvulsive therapy (ECT),Highly effective,major unipolar depression,Unipolar Depression,"ECT is arguably the most effective treatment modality in psychiatry, and its superiority over pharmacotherapy for major unipolar depression is widely supported."
3,Ketamine,Ketamine,Results,rapid effect on resistant depression and acute suicidal ideation,rapid effects,Intravenous sub-anesthetic dose of ketamine have very quick effects on resistant unipolar and possibly bipolar depression and acute suicidal ideation.
4,CBT,Cognitive Behavioral Therapy (CBT),first-line treatment,mild to moderate Major Depressive Disorder,MDD,"Based on significant clinical evidence, CBT is recommended as the initial treatment method for mild to moderate MDD."
5,MAOIs,Monoamine Oxidase Inhibitors (MAOIs),Less commonly used,due to their irreversible inhibition of monoamine oxidase and numerous side effects,reduced usage,"Due to their irreversible inhibition of monoamine oxidase, MOAIs have numerous side effects such as hepatotoxicity and hypertensive crisis, that lead to lethal intracranial hemorrhage."
6,Psychoeducation,Psycho-education,Benefits,"improved clinical course, treatment adherence, and psychosocial function in patients with depression",Clinical improvement,"Psycho-education has been highlighted for its role in improving the clinical course, treatment adherence, and psychosocial function in patients with depression."
7,MBCT,Mindfulness-Based Cognitive Therapy (MBCT),Treats,preventing depressive relapse,Relapse prevention,"Studies have shown that MBCT treatment during remission reduces relapse, making it a potential alternative to reduce or even stop antidepressant treatment without increasing the risk of depressive recurrence, especially for patients at high risk of relapse."
8,RTMS,Repetitive Transcranial Magnetic Stimulation (RTMS),More effective,when combined with antidepressants than placebo conditions with mild side effects and good acceptability,Combination efficacy,"Treatment combining RTMS and antidepressants was significantly more effective than placebo conditions, with mild side effects and good acceptability."
9,IPT,Interpersonal Therapy (IPT),first-line treatment,mild to moderate major depressive episode in adults,Adult MDD,"IPT, like CBT, is a first-line treatment for mild to moderate major depressive episodes in adults; it is also a well-established intervention for adolescent depression."
0,SSRIs,Selective Serotonin Reuptake Inhibitors (SSRIs),first-line treatment,Major Depression,Major Depression,most guidelines currently recommend SSRIs as the first-line treatment for patients with major depression
1,SNRIs,Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs),second-line treatment,patients who do not respond to SSRIs,SSRI non-responders,clinical guidelines commonly recommend prescribing SNRI to patients who do not respond to SSRIs
2,ECT,Electroconvulsive therapy (ECT),Highly effective,Major unipolar depression,Major unipolar depression,"ECT is arguably the most effective treatment modality in psychiatry, and its superiority over pharmacotherapy for major unipolar depression is widely supported"
3,rTMS,Repetitive Transcranial Magnetic Stimulation (rTMS),Widely used,depression research,Depression research,"this method, which is a type of biological stimulation that affects brain metabolism and neuronal electrical activity, has been widely used in research on depression"
4,MAOIs,Monoamine Oxidase Inhibitors (MAOIs),Less commonly used,over time due to side effects,Due to side effects,"due to their irreversible inhibition of monoamine oxidase, MAOIs have numerous side effects, such as hepatotoxicity and hypertensive crisis, that have made them less commonly used over time"
5,CBT,Cognitive Behavioral Therapy (CBT),Overview,targets depressed patients' irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,Cognitive corrections,CBT targets depressed patients' irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them
6,IPT,Interpersonal Therapy (IPT),first-line treatment,mild to moderate major depressive episodes in adults and well-established intervention for adolescents with depression,Mild to moderate depression,"IPT, like CBT, is a first-line treatment for mild to moderate major depressive episodes in adults; it is also a well-established intervention for adolescents with depression"
0,SSRIs,Selective Serotonin Reuptake Inhibitors (SSRIs),first-line treatment,major depression,Major Depression,most guideline currently recommend SSRIs as the first-line treatment for patient with major depression.
1,MAOIs,Monoamine Oxidase Inhibitors (MAOIs),less commonly used,due to irreversible inhibition causing numerous side effects,Side effects,"due to their irreversible inhibition of monoamine oxidase, MOAIs have numerous side effects... MAOIs have become less commonly used over time."
2,ECT,Electroconvulsive Therapy (ECT),highly effective,severe and psychotic depression,Severe and Psychotic Depression,"ECT be arguably the most effective treatment modality in psychiatry, and its superiority over pharmacotherapy for major unipolar depression be widely support."
3,rTMS,Repetitive Transcranial Magnetic Stimulation (rTMS),treats,depression with improvement in symptoms,Improvement in symptoms,recent literature show a significant difference between rTMS and fictitious stimulation regarding its improvement in depressive symptom.
4,Ketamine,Ketamine,side effects,"dizziness, neurotoxicity, cognitive dysfunction, psychosis, dissociation",Several side effects,"common adverse effect of ketamine include dizziness, neurotoxicity, cognitive dysfunction, blur vision, psychosis, dissociation"
5,VNS,Vagus Nerve Stimulation (VNS),treats,resistant unilateral or bipolar depression,Resistant Depression,vns be a therapeutic method that have been used for the last sixteen years to treat resistant unilateral or bipolar depression
6,SSRIs,Selective Serotonin Reuptake Inhibitors (SSRIs),side effects,"sexual and digestive issues, irritability, anxiety, insomnia, and headache",Various side effects,"they have elicited different tolerance rates and side effects - mostly sexual and digestive... as irritability, anxiety, insomnia, and headache"
7,Exercise,Physical Exercise,definition,recommended non-pharmacological treatment to alleviate symptoms and prevent relapse of depression,Depression Treatment,recommend that depressed patients perform regular physical activity to alleviate symptoms and prevent relapse
0,Mirtazapine,Mirtazapine,More effective,"duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",various antidepressants,"""Mirtazapine, escitalopram, venlafaxine, and sertraline were significantly more efficacious than duloxetine (odds ratio [OR] 1·39, 1·33, 1·30 and 1·27, respectively), fluoxetine (1·37, 1·32, 1·28, and 1·25, respectively), fluvoxamine (1·41, 1·35, 1·30, and 1·27, respectively), paroxetine (1·35, 1·30, 1·27, and 1·22, respectively), and reboxetine (2·03, 1·95, 1·89, and 1·85, respectively)."""
1,Escitalopram,Escitalopram,More effective,"duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",various antidepressants,"""Mirtazapine, escitalopram, venlafaxine, and sertraline were significantly more efficacious than duloxetine (odds ratio [OR] 1·39, 1·33, 1·30 and 1·27, respectively), fluoxetine (1·37, 1·32, 1·28, and 1·25, respectively), fluvoxamine (1·41, 1·35, 1·30, and 1·27, respectively), paroxetine (1·35, 1·30, 1·27, and 1·22, respectively), and reboxetine (2·03, 1·95, 1·89, and 1·85, respectively)."""
2,Venlafaxine,Venlafaxine,More effective,"duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",various antidepressants,"""Mirtazapine, escitalopram, venlafaxine, and sertraline were significantly more efficacious than duloxetine (odds ratio [OR] 1·39, 1·33, 1·30 and 1·27, respectively), fluoxetine (1·37, 1·32, 1·28, and 1·25, respectively), fluvoxamine (1·41, 1·35, 1·30, and 1·27, respectively), paroxetine (1·35, 1·30, 1·27, and 1·22, respectively), and reboxetine (2·03, 1·95, 1·89, and 1·85, respectively)."""
3,Sertraline,Sertraline,More effective,"duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",various antidepressants,"""Mirtazapine, escitalopram, venlafaxine, and sertraline were significantly more efficacious than duloxetine (odds ratio [OR] 1·39, 1·33, 1·30 and 1·27, respectively), fluoxetine (1·37, 1·32, 1·28, and 1·25, respectively), fluvoxamine (1·41, 1·35, 1·30, and 1·27, respectively), paroxetine (1·35, 1·30, 1·27, and 1·22, respectively), and reboxetine (2·03, 1·95, 1·89, and 1·85, respectively)."""
4,Escitalopram,Escitalopram,first-line treatment,major depression,major depression,"""clinically important differences exist between commonly prescribed antidepressants for both efficacy and acceptability in favour of escitalopram and sertraline. Sertraline might be the best choice when starting treatment for moderate to severe major depression in adults because it has the most favourable balance between benefits, acceptability, and acquisition cost."""
5,Sertraline,Sertraline,first-line treatment,major depression,major depression,"""clinically important differences exist between commonly prescribed antidepressants for both efficacy and acceptability in favour of escitalopram and sertraline. Sertraline might be the best choice when starting treatment for moderate to severe major depression in adults because it has the most favourable balance between benefits, acceptability, and acquisition cost."""
6,Reboxetine,Reboxetine,Less effective,all other tested antidepressants,all other tested antidepressants,"""Reboxetine was significantly less efficacious than all the other antidepressants tested."""
7,Escitalopram,Escitalopram,More commonly used,treatment of major depression due to better acceptability and fewer discontinuations,major depression treatment,"""Escitalopram and sertraline show the best profile of acceptability, leading to significantly fewer discontinuations than do duloxetine, fluvoxamine, paroxetine, reboxetine, and venlafaxine."""
8,Sertraline,Sertraline,More commonly used,treatment of major depression due to better acceptability and fewer discontinuations,major depression treatment,"""Escitalopram and sertraline show the best profile of acceptability, leading to significantly fewer discontinuations than do duloxetine, fluvoxamine, paroxetine, reboxetine, and venlafaxine."""
0,SSRIs,Selective Serotonin Reuptake Inhibitors (SSRIs),first-line treatment,Major Depressive Disorder,MDD,most guideline currently recommend ssris as the first-line treatment for patient with major depression
1,venlafaxine,venlafaxine,Comparable to,tricyclic antidepressants (TCAs),TCAs,venlafaxine's efficacy is comparable to that of tcas
2,escitalopram,escitalopram and sertraline,More effective,other second-generation antidepressants,other antidepressants,"mirtazapine, escitalopram, venlafaxine, and sertraline were significantly more efficacious than duloxetine, fluoxetine, fluvoxamine, paroxetine, and reboxetine."
3,reboxetine,reboxetine,Less effective,all the other antidepressants tested,other antidepressants,reboxetine was significantly less efficacious than all the other antidepressants tested.
4,escitalopram and sertraline,escitalopram and sertraline,side effects,"fewer discontinuations than duloxetine, fluvoxamine, paroxetine, reboxetine, and venlafaxine",fewer discontinuations,"escitalopram and sertraline show the best profile of acceptability, leading to significantly fewer discontinuations than do duloxetine, fluvoxamine, paroxetine, reboxetine, and venlafaxine."
5,sertraline,sertraline,More commonly used,treatment for moderate to severe major depression in adults,treat depression,"sertraline might be the best choice when starting treatment for moderate to severe major depression in adults because it has the most favourable balance between benefits, acceptability, and acquisition cost."
6,bupropion,bupropion,side effects,minimal weight gain or even weight loss,weight loss,"bupropion's mechanism of action remains unclear, though it is classified as a norepinephrine and dopamine reuptake inhibitor. it appears to have a more activating profile than ssris that are modestly superior to bupropion in patients with mdd."
7,ketamine,ketamine,side effects,"dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms",multiple side effects,"common adverse effects of ketamine include dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms."
8,ECT,Electroconvulsive therapy (ECT),Highly effective,major unipolar depression,unipolar depression,"ect is arguably the most effective treatment modality in psychiatry, and its superiority over pharmacotherapy for major unipolar depression is widely supported"
0,SSRIs,Selective Serotonin Reuptake Inhibitors (SSRIs),first-line treatment,major depression,major depression,most guideline currently recommend SSRIs as the first-line treatment for patients with major depression.
1,SSRIs,Selective Serotonin Reuptake Inhibitors (SSRIs),side effects,"sexual and digestive (nausea and loss of appetite), as well as irritability, anxiety, insomnia, and headache",side effects,"currently available SSRIs elicit different tolerance rates and side effects - mostly sexual and digestive (nausea and loss of appetite), as well as irritability, anxiety, insomnia, and headache."
2,escitalopram,escitalopram,more effective than,"duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",multiple antidepressants,"escitalopram, mirtazapine, venlafaxine, and sertraline were significantly more efficacious than duloxetine, fluoxetine, fluvoxamine, paroxetine, and reboxetine."
3,reboxetine,reboxetine,less effective than,all other tested antidepressants,all other antidepressants,reboxetine was significantly less efficacious than all the other antidepressants tested.
4,escitalopram,escitalopram,more tolerable than,"duloxetine, fluvoxamine, paroxetine, reboxetine",multiple antidepressants,"escitalopram and sertraline show the best profile of acceptability, leading to significantly fewer discontinuations than do duloxetine, fluvoxamine, paroxetine, reboxetine, and venlafaxine."
5,sertraline,sertraline,more tolerable than,"duloxetine, fluvoxamine, paroxetine, reboxetine",multiple antidepressants,"escitalopram and sertraline show the best profile of acceptability, leading to significantly fewer discontinuations than do duloxetine, fluvoxamine, paroxetine, reboxetine, and venlafaxine."
6,ECT,Electroconvulsive therapy (ECT),treats,major unipolar depression,major unipolar depression,"ECT is arguably the most effective treatment modality in psychiatry, and its superiority over pharmacotherapy for major unipolar depression is widely supported."
0,Escitalopram,Escitalopram,More effective,"Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Several antidepressants,"Escitalopram, mirtazapine, sertraline, and venlafaxine were significantly more efficacious than duloxetine, fluoxetine, fluvoxamine, paroxetine, and reboxetine."
1,Sertraline,Sertraline,More effective,"Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Several antidepressants,"Escitalopram, mirtazapine, sertraline, and venlafaxine were significantly more efficacious than duloxetine, fluoxetine, fluvoxamine, paroxetine, and reboxetine."
2,Mirtazapine,Mirtazapine,More effective,"Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Several antidepressants,"Escitalopram, mirtazapine, sertraline, and venlafaxine were significantly more efficacious than duloxetine, fluoxetine, fluvoxamine, paroxetine, and reboxetine."
3,Venlafaxine,Venlafaxine,More effective,"Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Several antidepressants,"Escitalopram, mirtazapine, sertraline, and venlafaxine were significantly more efficacious than duloxetine, fluoxetine, fluvoxamine, paroxetine, and reboxetine."
4,Reboxetine,Reboxetine,Less effective,all other 11 antidepressants,Other antidepressants,Reboxetine was significantly less efficacious than all the other 11 antidepressants tested.
5,Escitalopram,Escitalopram,first-line treatment,adults with moderate to severe major depression,Moderate to severe major depression,Escitalopram and sertraline might be the best choice when starting treatment for moderate to severe major depression in adults because they have the best possible balance between efficacy and acceptability.
6,Sertraline,Sertraline,first-line treatment,adults with moderate to severe major depression,Moderate to severe major depression,Escitalopram and sertraline might be the best choice when starting treatment for moderate to severe major depression in adults because they have the best possible balance between efficacy and acceptability.
7,Major Depression,Major Depressive Disorder,Treats,"Escitalopram, Sertraline, Mirtazapine, Venlafaxine",Several effective antidepressants,"Our findings suggest that esitalopram and sertraline might be the best choice when starting treatment for moderate to severe major depression in adults, showing significant efficacy and acceptability."
0,Sertraline,Sertraline,first-line treatment,moderate to severe major depression in adults,moderate to severe major depression in adults,"""sertraline might be the best choice when starting treatment for moderate to severe major depression in adults because it has the most favourable balance between benefits, acceptability, and acquisition cost."""
1,Escitalopram,Escitalopram,first-line treatment,moderate to severe major depression in adults,moderate to severe major depression in adults,"""escitalopram and sertraline might be the best choice when starting treatment for moderate to severe major depression in adults because they have the most favourable balance between efficacy and acceptability."""
2,Reboxetine,Reboxetine,less effective,all other 11 antidepressants for treating major depression,all other 11 antidepressants,"""Reboxetine was significantly less efficacious than all the other 11 antidepressants tested."""
3,Escitalopram,Escitalopram,highly effective,moderate to severe major depression in adults,major depression,"""escitalopram, mirtazapine, venlafaxine, and sertraline were significantly more efficacious [...] reboxetine was significantly less efficacious than all the other 11 antidepressants tested."""
4,Mirtazapine,Mirtazapine,highly effective,Major Depressive Disorder,Major Depressive Disorder,"""mirtazapine, escitalopram, venlafaxine, and sertraline were significantly more efficacious [...] reboxetine was significantly less efficacious than all the other 11 antidepressants tested."""
5,Venlafaxine,Venlafaxine,highly effective,Major Depressive Disorder,Major Depressive Disorder,"""mirtazapine, escitalopram, venlafaxine, and sertraline were significantly more efficacious [...] reboxetine was significantly less efficacious than all the other 11 antidepressants tested."""
6,Sertraline,Sertraline,highly effective,Major Depressive Disorder,Major Depressive Disorder,"""mirtazapine, escitalopram, venlafaxine, and sertraline were significantly more efficacious [...] reboxetine was significantly less efficacious than all the other 11 antidepressants tested."""
7,Reboxetine,Reboxetine,not effective,as a routine first-line acute treatment for major depression,first-line acute treatment for major depression,"""therefore, reboxetine should not be used as a routine first-line acute treatment for major depression."""
8,Antidepressants,"Antidepressants (e.g., bupropion, citalopram, escitalopram, sertraline)",side effects,varies based on the medication,varies,The text discusses various antidepressants and their possible side effects without directly quoting side effects.
9,Antidepressants,"Antidepressants (e.g., sertraline, escitalopram)",treats,Major Depressive Disorder,Major Depressive Disorder,The text discusses sertraline and escitalopram as first-line treatments for moderate to severe major depression in adults.
10,Antidepressants,"Antidepressants (e.g., escitalopram, sertraline)",more commonly used,for their favorable balance between efficacy and acceptability in treating Major Depressive Disorder,favorable balance between efficacy and acceptability,"""escitalopram and sertraline might be the best choice when starting treatment for moderate to severe major depression in adults because they have the most favourable balance between efficacy and acceptability."""
11,Reboxetine,Reboxetine,less commonly used,due to being less efficacious and less tolerable compared to other antidepressants,less efficacious and less tolerable,"""Reboxetine was significantly less efficacious than all the other 11 antidepressants tested."" and ""reboxetine should not be used as a routine first-line acute treatment for major depression."""
0,Escitalopram,Escitalopram,More effective,"Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Several antidepressants,"escitalopram, mirtazapine, sertraline, and venlafaxine were significantly more efficacious than duloxetine, fluoxetine, fluvoxamine, paroxetine, and reboxetine."
1,Mirtazapine,Mirtazapine,More effective,"Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Several antidepressants,"escitalopram, mirtazapine, sertraline, and venlafaxine were significantly more efficacious than duloxetine, fluoxetine, fluvoxamine, paroxetine, and reboxetine."
2,Sertraline,Sertraline,More effective,"Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Several antidepressants,"escitalopram, mirtazapine, sertraline, and venlafaxine were significantly more efficacious than duloxetine, fluoxetine, fluvoxamine, paroxetine, and reboxetine."
3,Venlafaxine,Venlafaxine,More effective,"Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Several antidepressants,"escitalopram, mirtazapine, sertraline, and venlafaxine were significantly more efficacious than duloxetine, fluoxetine, fluvoxamine, paroxetine, and reboxetine."
4,Sertraline,Sertraline,Recommended,as a first choice for the treatment of moderate to severe major depression,First choice treatment,"Sertraline might be the best choice when initiating treatment for moderate to severe major depression in adults because it has the most favourable balance between benefits, acceptability, and acquisition cost."
5,Reboxetine,Reboxetine,Less effective,"Escitalopram, Mirtazapine, Sertraline, Venlafaxine",Several antidepressants,reboxetine was significantly less efficacious than all the other 11 antidepressants.
6,"Escitalopram, Sertraline","Escitalopram, Sertraline",Well tolerated,"Duloxetine, Paroxetine",Several antidepressants,"Escitalopram and sertraline showed the best profile of acceptability, leading to significantly fewer discontinuations than duloxetine and paroxetine."
7,"Bupropion, Citalopram","Bupropion, Citalopram",Well tolerated,"Duloxetine, Fluvoxamine, Paroxetine, Reboxetine",Several antidepressants,"Bupropion and citalopram were better tolerated than other antidepressants, such as duloxetine, fluvoxamine, paroxetine, and reboxetine."
0,Anxious depression,Anxious depression,More common than,nonanxious depression,nonanxious depression,Anxious depression is associated with poor acute outcome than nonanxious depression following antidepressant treatment.
1,Citalopram,Citalopram,first-line treatment,major depressive disorder,major depressive disorder,STAR*D study provided citalopram as the first-line treatment in level 1.
2,Anxious depression,Anxious depression,Associated with,"higher rates of severity, illness chronicity, functional impairment, and risk of suicidality","higher rates of severity, illness chronicity, functional impairment, risk of suicidality","Anxious depression is associated with higher rates of severity, illness chronicity, functional impairment, and risk of suicidality compared to nonanxious depression."
3,Anxious depression,Anxious depression,Symptom,major depressive disorder with high levels of anxiety symptoms,major depressive disorder with high levels of anxiety symptoms,Anxious depression is defined as major depressive disorder with high levels of anxiety symptoms.
4,Citalopram,Citalopram,Treats,major depressive disorder in adults,major depressive disorder in adults,All participants received citalopram to treat major depressive disorder in level 1 of STAR*D
5,Anxious depression,Anxious depression,Less effective,citalopram treatment in achieving remission compared to nonanxious depression,citalopram treatment in achieving remission compared to nonanxious depression,Anxious depression is associated with less likelihood of remission with citalopram treatment compared to nonanxious depression in level 1 of STAR*D.
6,Anxious depression,Anxious depression,Definition,major depressive disorder with a baseline HAMD anxiety/somatization factor score of 7 or higher,major depressive disorder with a baseline HAMD anxiety/somatization factor score of 7 or higher,Anxious depression was defined as major depressive disorder with a baseline 17-item Hamilton Rating Scale for Depression (HAMD) anxiety/somatization factor score of 7 or higher.
0,Anxious depression,Anxious depression,More common than,nonanxious depression,nonanxious depression,"Anxious depression be significantly more common than nonanxious depre - sion among African Americans than in other racial / ethnicgroup ; among Hispanic than non - Hispanic ; amongthose see in primary care setting than those in psychiat - ric care setting ; among those who be unemployed thanthose who be employ ; among those who be mar - rie , divorced , or widow than among those who hadnever marry ; and among those with less education , those with public insurance , and those with less income."
1,Anxious depression,Anxious depression,Associated with,"higher rates of suicidality, unemployment, less education, public insurance, and lower income",negative life impacts,"In addition , anxious depression be associate with a great likelihood of reporte suicidal ideation on the ham - d , a personal his - tory of attempt suicide , and a family history of drug abuse . Further, anxious depression be significantly more common among African Americans, Hispanics, those seen in primary care, unemployed, those with less education, those with public insurance, and those with lower income."
2,Anxious depression,Anxious depression,More effective than,nonanxious depression,nonanxious depression,remission was significantly less likely and took longer to occur in these patients than in those with nonanxious depression.
3,Anxious depression,Anxious depression,Associated with,significant clinical and sociodemographic differences from those without anxious depression,differences,Anxious depression be also associate with significant clinical and sociodemographic differences from those without anxious depression.
4,All Depression,All Depression,Treats,Cognitive Behavioral Therapy (CBT),CBT," Treatment could last up to 14 weeks in each level, involving methods that include elements of CBT."
5,Citalopram,Citalopram,first-line treatment,nonpsychotic major depressive disorder,nonpsychotic MDD,all participants with nonpsychotic major depressive disorder received citalopram in level 1 of STAR*D.
0,Anxious depression,Anxious depression,More common than,nonanxious depression,nonanxious depression,"Anxious depression --> more common than -> nonanxious depression -> in -> African American group, Hispanics, Primary Care Patients, Unemployed, Married then Divorced/Widowed, Less, Education, Public insurance, Lower-income"
1,Anxious depression,Anxious depression,Associated with,lower remission rates compared to nonanxious depression following antidepressant treatment,lower remission rates,Anxious depression be significantly less likely and take longer to occur in these patients than in those with nonanxious depression
2,Anxious depression,Anxious depression,Associated with,greater rate of side effects and serious adverse events compared to nonanxious depression,greater rate of side effects,The anxious depression group had significantly higher mean QIDS-SR score at exit and significantly lower raw QIDS-SR change score and percentage change in QIDS-SR score than the nonanxious depression group
3,Citalopram,Citalopram,first-line treatment,major depressive disorder in STAR*D Level 1,major depressive disorder,An integral part of our measurement-based care intervention ... Citalopram
0,Anxious depression,Anxious depression,More common than,nonanxious depression,nonanxious depression,"Anxious depression more common than nonanxious depression in African American group, Hispanics, Primary Care Patients, Unemployed, Married then Divorced/Widowed, Less, Education, Public insurance, Lower-income"
1,Anxious depression,Anxious depression,Associated with,poor acute outcome than nonanxious depression following antidepressant treatment,poor outcome,Anxious depression is associated with poor acute outcome than nonanxious depression following antidepressant treatment.
2,Anxious depression,Anxious depression,Associated with,"Greater severity of depression, more concurrent anxiety disorder, more melancholic/endogenous feature, unemployment, less education, marital status (divorced/widowed), public insurance, lower income",worse clinical features,Anxious depression is associated with worse clinical features compared to nonanxious depression.
3,Citalopram,Citalopram,first-line treatment,major depressive disorder in STAR*D study,MDD,Citalopram was used as a first-line treatment for major depressive disorder in the STAR*D study.
4,Anxious depression,Anxious depression,Less effective,treatment with citalopram than nonanxious depression,citalopram treatment,Patients with anxious depression were less likely to achieve remission with citalopram treatment than those with nonanxious depression.
5,Anxious depression,Anxious depression,Associated with,"greater side effects frequency, intensity, burden, and more serious adverse events during citalopram treatment",more side effects and serious adverse events,"Patients with anxious depression experienced a greater frequency, intensity, and burden of side effects, as well as more serious adverse events during citalopram treatment."
6,Citalopram,Citalopram,Treats,major depressive disorder but with differentiated effectiveness in anxious vs nonanxious depression,MDD with varied effectiveness,"Citalopram treats major depressive disorder, showing differentiated effectiveness in anxious versus nonanxious depression."
0,Anxious depression,Anxious depression,More common than,nonanxious depression,nonanxious depression,"Anxious depression is significantly more common than nonanxious depression among African Americans than in other racial/ethnic groups; among Hispanics than non-Hispanics; among those seen in primary care settings than those in psychiatric care settings; among those who are unemployed than those who are employed; among those who are married, divorced, or widowed than among those who had never married; and among those with less education, those with public insurance, and those with lower income."
1,Anxious depression,Anxious depression,Associated with,"unemployment, low education, public insurance, lower income, severe depression, greater perceived physical impairment, diminished quality of life, later onset of major depression, more concurrent anxiety disorders, more melancholic/endogenous features, more medical comorbidity",multiple hardships,"Anxious depression is associated with unemployment, low education, public insurance, lower income, severe depression, greater perceived physical impairment, diminished quality of life, later onset of major depression, more concurrent anxiety disorders, melancholic/endogenous features, and more medical comorbidity."
2,Anxious depression,Anxious depression,Less effective,citalopram treatment compared to those with nonanxious depression,citalopram,Anxious depression is less likely to respond or to remit with citalopram treatment compared to those with nonanxious depression.
3,Anxious depression,Anxious depression,Associated with,"greater side effect frequency, intensity, burden, and more serious adverse events compared to nonanxious depression",side effects and adverse events,"Despite similar citalopram dosages in both groups, anxious depression is associated with greater side effect frequency, intensity, burden, and more serious adverse events, including psychiatric nature, compared to nonanxious depression."
4,Citalopram,Citalopram,first-line treatment,Major depressive disorder in the STAR*D Level 1 treatment,MDD in STAR*D Level 1,Citalopram was used as the first-line treatment for major depressive disorder in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Level 1 treatment.
5,Anxious depression,Anxious depression,Benefits,Anxious depression taking longer to remit with treatment than nonanxious depression,longer remission time,Those with nonanxious depression achieve remission and response sooner on average than those with anxious depression.
6,Anxious depression,Anxious depression,Associated with,"low socioeconomic status, great severity of depression, late onset of depression, high physical illness burden, and significant clinical and sociodemographic differences",various hardships,"Anxious depression is associated with low socioeconomic status, great severity of depression, late onset of depression, high physical illness burden, and significant clinical and sociodemographic differences."
